Background: Immune cell-mediated inflammation is an essential process for mounting a repair response after myocardial infarction (MI). The sympathetic nervous system is known to regulate immune system function through β-adrenergic receptors (βARs); however, their role in regulating immune cell responses to acute cardiac injury is unknown.
i nflammation is critical for initiating reparative processes after ischemic injury. 1 After myocardial infarction (MI), an intense inflammatory response is initiated, leading to recruitment of proinflammatory leukocytes, including monocytes, neutrophils, and mast cells. 1-6 Secreted factors from these proinflammatory cell populations recruit and activate reparative cell populations to promote extracellular matrix deposition and vascularization. 7, 8 This rapid inflammatory response is necessary for healing and preserving the structure of the left ventricle (LV) after MI because dysregulation of this process results in increased cardiomyocyte death and degradation of the extracellular matrix. 9 Sympathetic nervous system regulation of immune responses is well established, 10 and β-adrenergic receptor (βAR) expression has been reported on virtually all immune cell types. All 3 βAR subtypes are expressed on various hematopoietic cell-derived immune cell populations, with βAR subtype expression varying widely between populations and immune cell activation states. 11 Although the role of β 1 AR in the immune system is not well established, β 1 AR expression has been shown to be limited primarily to cells of the innate immune system, where it regulates inflammatory mediator production. 12, 13 β 2 AR is the most highly and widely expressed βAR isoform, 10, 14 with similar levels of immune cell expression in rodents and humans, 10, 14 and is known to regulate a number of functions, including hematopoiesis, lymphocyte homing, and immune cell maturation. 10 However, the focus of many of these studies involved the effect of β 2 AR on adaptive immune responses, whereas its involvement in mediating early, innate immune responses and initiation of inflammation remains unclear. 10, 15, 16 β 3 AR has been shown to be important in early stages of hematopoiesis for mediating immune cell mobilization and egress from the bone marrow (BM). [17] [18] [19] Although βAR subtype expression and function vary in the immune system, the role of immune cell-expressed βAR in the acute inflammatory response after MI has yet to be elucidated.
In the present study, the impact of immune cellspecific βAR expression on cardiac inflammation and remodeling after MI was investigated through the use of chimeric mice that lack specific βAR isoforms on cells of hematopoietic origin. We demonstrate that β 2 AR is essential in initiating early immune responses after acute cardiac injury and that targeting immune cell-expressed β 2 AR may provide a novel therapeutic strategy for preventing adverse effects after MI.
MethOds rationale and study design
The purpose of this study was to investigate the impact of βAR in regulating immune responses after MI. To differentiate the effects of immune cell-expressed βAR from cardiac-expressed βAR, we generated chimeric mice using a BM transplantation (BMT) approach in which wild-type (WT) recipient mice received WT control or βAR subtype-specific knockout (KO) BM to produce immune cell-and βAR isoform-specific KO mice. These mice were subjected to sham or MI surgery, and survival outcome and immune responses were examined, along with the mechanisms of observed changes.
BM transplantation
WT C57BL/6 recipient mice (male; age, 8 weeks) were lethally irradiated with 950 rads using x-ray irradiation to remove endogenous BM cells. Donor BM isolated from the femurs of β 1 ARKO, β 2 ARKO, β 3 ARKO, or WT C57BL/6 mice was introduced by retro-orbital injection (1×10 7 cells) within 24 hours of irradiation. BM was allowed to reconstitute for 1 month before MI surgery. Reconstitution was confirmed at the conclusion of the study for each mouse with reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis for β 1 AAR, β 2 AR, and β 3 AR expression on recipient BM. All animal procedures were performed in accordance with the Institutional Animal Care and Use clinical Perspective What is new?
• Using chimeric mice, we demonstrate that immune cell-specific β 2 -adrenergic receptor (β 2 AR) expression is essential to the repair process after myocardial infarction. In the absence of β 2 AR, vascular cell adhesion molecule-1 expression is increased in leukocytes, inducing their splenic retention after injury and leading to impaired scar formation, followed by rupture and death. • Vascular cell adhesion molecule-1 expression is regulated dynamically by βAR ligands, including β-blockers, in both mouse and human tissues. Splenectomy partially restores β 2 AR-deficient leukocyte infiltration into the heart after injury, and gene therapy to rescue leukocyte β 2 AR expression completely restored all injury responses to that observed in normal mice.
What are the clinical implications?
• βARs regulate cardiac function and remodeling after injury, classically through their effects in cardiomyocytes, and are targeted by β-blockers to help prevent detrimental myocardial remodeling. However, our findings indicate that inhibition/deletion of immune cell-expressed β 2 AR causes leukocyte dysfunction and altered immunomodulatory responses to acute injury. • These results have important clinical implications because β-blockers are used frequently in patients around the time of myocardial infarction and perioperatively for noncardiac surgeries with uncertain mortality risk. • Thus, understanding the essential role for β 2 AR in mediating immune cell responses will inform strategies for β-blocker, or βAR agonist, administration after acute injury.
coronary artery Occlusion surgery
Myocardial infarction was induced as previously described. 20 Mice were anesthetized with 2% isoflurane inhalation. A small skin incision was made, and the pectoral muscles were retracted to expose the fourth intercostal space. A small hole was made, and the heart was popped out. The left coronary artery was sutured ≈3 mm from its origin, and the heart was placed back into the intrathoracic space, followed by closure of muscle and skin. Animals received a single dose (0.3 mg/ kg) of buprenorphine immediately after surgery.
splenectomy surgery
Mice were anesthetized as above, and a small incision was made in the left subcostal abdominal wall. Sutures were placed around the splenic vasculature, and the spleen was removed.
The incision was closed in 2 layers, peritoneum and skin, with suture. Animals received a single dose (0.3 mg/kg) of buprenorphine immediately after surgery.
echocardiography
Cardiac function was assessed via transthoracic 2-dimensional echocardiography performed at baseline and at weekly intervals after MI with a 12-mHz probe on mice anesthetized with isoflurane (1.5% 
histological analysis
Excised hearts were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned at 5-μm thickness. Deparaffinized sections were stained for hematoxylin-eosin (Sigma-Aldrich).
NIS Elements software was used to measure infarct size and to visualize cell infiltration and morphology. Immunohistochemistry was performed on deparaffinized sections to examine the infiltration of various immune cell types. Antigens were retrieved with a citrate-based antigenunmasking solution (Vector Laboratories). Hearts were blocked (10% FBS/PBS), and a 0.3% H 2 O 2 solution was used to block endogenous peroxide activity in sections used for immunohistochemical staining. Hearts were incubated with antibodies against CD3 (1:100; Abcam), CD68 (1:100; Abcam), major basic protein (obtained from Nancy and Jamie Lee Laboratories; Mayo Clinic), mast cell tryptase (1:100; Abcam), myeloperoxidase (1:100; Santa Cruz), or VCAM-1 (1:100; Santa Cruz). Washed slides were incubated with the appropriate secondary antibodies, anti-mouse horseradish peroxidase (1:1000; GE Healthcare), anti-goat horseradish peroxidase (1:1000; Santa Cruz), anti-goat Alexa Fluor 647 (1:1000; Invitrogen), and anti-rabbit Alexa Fluor 647 (1:1000; Invitrogen), followed by staining with DAPI for immunofluorescence or hematoxylin for immunohistochemical staining. Immunofluorescent stained hearts were mounted with the Prolong Gold Antifade Reagent (Invitrogen). Immunohistochemically stained hearts were developed with a DAB Substrate Kit (Vector Laboratories) and mounted with Permount Mounting Media (Thermo Scientific). Staining was visualized on a Nikon Eclipse microscope at ×20 magnification, and NIS Elements software was used for recording images and image analysis. Images were quantified as the number of positive cells per area.
Flow cytometry
Flow cytometry analysis of immune cell populations was performed on cells isolated from blood and BM. Immune cells were separated with an antibody against CD45-FITC (BD Biosciences) and sorted on an LSRII flow cytometer for size and granularity by forward scatter and side scatter. Analysis was performed with Flowjo software.
statistical analysis
Data presented are expressed as mean±SD for continuous variables and as count and/or percentage for categorical variables. Comparisons of a continuous variable between different treatment groups were performed with the nonparametric Kruskal-Wallis test for ≥3 groups and the exact Wilcoxon rank-sum test for 2 groups because of the small group sizes to guard against possibly nonnormally distributed data. Comparisons of a survival end point between treatment groups were performed with the log-rank test. When data were collected over time on the same set of animals such as fractional shortening in Figure 1B , they were analyzed with a mixed-effects model to take into account the correlation among repeated measures and the potential nonconstant variability over time across different groups. Multiple pairwise comparison adjustments were made with Bonferroni or Dunnett correction as appropriate. Values of P<0.05 were considered statistically significant. P values and n (group size) values are reported in the figure legends. All statistical analyses were performed with SAS version 9.3 software (SAS Institute Inc).
results lack of immune cell-expressed β 2 ar increases Mortality after acute Myocardial injury
To examine the contribution of immune cell-specific βAR subtype expression on survival and cardiac function after MI, chimeric animals were generated via WT, β 1 ARKO, β 2 ARKO, or β 3 ARKO BMT into irradiated recipient WT mice. β 1 AR, β 2 AR, and β 3 AR expression was examined by RT-qPCR on reconstituted BM from all animals ( Figure 1A) , confirming that β 1 AR, β 2 AR, and β 3 AR were knocked out in their respective BM with no differences in the other 2 βAR subtypes. After reconstitution, the BMT mice underwent sham or MI surgery, and cardiac function was monitored via echocardiography ( Figure IA and Table  II in the online-only Data Supplement). LV contractility, wall thickness, and cardiac dimensions were significantly altered in each MI group, as shown by decreased percent fractional shortening ( Figure 1B ), increased LV hypertrophy, and increased LV dilation relative to sham animals, although no differences were evident between WT, β 1 ARKO, β 2 ARKO, and β 3 ARKO BMT groups. However, mortality rates among the BMT mice differed significantly after MI. All sham BMT mice displayed 100% survival, and WT BMT mice exhibited ≈20% mortality by 2 weeks after MI (Figure 1C) , consistent with prior studies in non-BMT mice. 20 β 1 ARKO and β 3 ARKO BMT animals had a small but nonsignificant increase in mortality after MI compared with WT BMT animals. Strikingly, β 2 AR BMT mice displayed 100% mortality after MI as a result of cardiac rupture, with death observed 4 to 12 days after MI. Although infarct size 1 day after MI was not different between WT and β 2 ARKO chimeric mice ( Figure IB and IC in the online-only Data Supplement), hematoxylin-eosin staining revealed wall thinning and weakening in β 2 ARKO BMT mice 4 days after MI compared with WT BMT hearts ( Figure 1D ), suggesting an impairment in early repair mechanisms.
lack of immune cell β 2 ar expression impairs leukocyte infiltration after acute Myocardial injury
A number of immune cell populations, including monocytes/macrophages, neutrophils, mast cells, and T cells, are known to be important for the initiation of wound healing and cardiac remodeling after MI. Because of the high mortality via cardiac rupture observed in β 2 AR BMT mice after MI, which could reflect decreased immune cell-initiated repair, we assessed whether WT and β 2 ARKO BMT mice display differences in MI-induced cardiac immune cell population infiltration. Immunostaining was performed to identify cells of monocyte/macrophage lineage (CD68), mast cells (tryptase), neutrophils (myeloperoxidase), eosinophils (major basic protein), and T cells (CD3) in sham BMT hearts and in the remote, Mice lacking immune cell-expressed β 2 ar have increased splenic retention of leukocyte Populations
Because overall immune populations are similar between WT and β 2 ARKO BMT mice but decreased leukocyte populations are observed in β 2 ARKO BMT hearts after MI, we aimed to determine whether splenic retention of leukocytes could play a role in this phenotype. Sham β 2 ARKO BMT mice had an increased spleen size compared with their WT BMT counterparts ( Figure 3A) , which was maintained after MI ( Figure 3B ). Leukocyte levels in spleen sections from WT or β 2 ARKO BMT mice were examined to determine whether an increase in leukocytes within the a, C57BL/6 mice receiving wild-type (WT), β 1 AR knockout (KO), β 2 ARKO, or β 3 ARKO bone marrow transplantation (BMT) were subjected to sham or MI surgery. Expression of β 1 AR, β 2 AR, and β 3 AR was assessed by reverse transcription-quantitative polymerase chain reaction on reconstituted WT, β 1 ARKO, β 2 ARKO, and β 3 ARKO BM and presented as relative quantitation (RQ)+RQ max . n=6 for all groups. Exact Wilcoxon rank-sum tests with multiple-comparison adjustment (3 comparisons). †P<0.01 versus WT. B, Left ventricular fractional shortening (FS) was measured at the short axis from the M mode with Visual Sonic Analysis software. Mixed-effects modeling for repeated-measures data with multiple-comparison adjustments was performed and indicated no significant differences compared with WT BMT. c, WT (n=9 for sham, n=11 for MI), β 1 ARKO (n=7 for sham, n=11 for MI), β 2 ARKO (n=10 for sham, n=14 for MI), or β 3 ARKO (n=7 for sham, n=18 for MI) BMT mice were monitored daily for survival. Log-rank tests with multiple-comparison adjustment (3 comparisons). ‡P<0.001 versus WT BMT MI. All sham groups had 100% survival after surgery. d, Hematoxylin-eosin staining for sham and 4-day post-MI hearts from WT and β 2 ARKO BMT mice.
β 2 ARKO BMT spleens could account for the splenomegaly observed between the 2 groups in sham animals ( Figure  V in the online-only Data Supplement) and 4 days after MI ( Figure 3C ). Increased levels of monocyte/macrophages, mast cells, and neutrophils ( Figure 3D ) were observed in β 2 ARKO BMT spleens compared with WT BMT mice, suggesting that β 2 ARKO leukocytes have an impaired ability to mobilize from the spleen to the heart after injury. splenic and Macrophage VcaM1 expression is sensitive to β 2 ar activity and expression in Mice and humans VCAM-1 expression on splenic macrophages has recently been identified as a hematopoietic stem cell retention factor important for splenic myelopoiesis. 23 To determine whether VCAM-1 levels were increased in the spleens of β 2 ARKO BMT mice, leading to the retention of myeloid populations, its expression was assessed in the spleens of WT or β 2 ARKO BMT mice.
Immunostaining indicated increased splenic VCAM-1 expression with localization in the red pulp, where macrophages reside ( Figure 4A and 4B ). Protein levels of VCAM-1 were confirmed to be elevated in β 2 ARKO chimeric mouse spleens compared with WT BMT mice via immunoblotting analysis ( Figure 4C and 4D ). Furthermore, transcript expression of VCAM-1 was increased in β 2 ARKO BMT spleens both basally and 4 days after MI ( Figure 4E ).
To determine whether β 2 AR stimulation alters VCAM-1 expression at a cellular level, WT BM-derived macrophages were treated with the β 2 AR-selective agonist salbutamol, which decreased VCAM-1 expression (Figure 4F) . Strikingly, salbutamol also decreased VCAM-1 expression in a human macrophage cell line ( Figure 4F ), confirming that β 2 AR-mediated alterations in VCAM-1 are translatable between species. Because VCAM-1 was decreased by β 2 AR stimulation, we next tested whether pharmacological inhibition of β 2 AR could reciprocally increase VCAM-1 expression. Indeed, treatment of human macrophages with the β 2 AR-selective antagonist ICI-118,551 ( Figure 4G ) increased VCAM-1 expression. Furthermore, VCAM-1 expression was significantly increased in the spleens of human subjects treated with the β-blocker metoprolol compared with age-and sex-matched subjects who had not taken a β-blocker ( Figure 4H ), demonstrating the clinical relevance of our findings.
Proximal β 2 AR signaling through either G protein-or βarrestin (βARR)-dependent pathways has been shown to exert distinct cellular effects. 21, 22 Thus, to determine the proximal mechanism through which β 2 AR controls VCAM-1 expression, lentiviral constructs were generated containing either β 2 AR TYY , which is unable to couple to Gα s , 22 or β 2 AR GRK− , which cannot be phosphorylated by GRK, 21 thereby preventing the recruitment of βARRs. Using BMderived macrophages from WT or β 2 ARKO mice, we showed VCAM-1 transcript expression to be increased in β 2 ARKO macrophages ( Figure 5A ). Lentivirus-mediated a, Representative images of spleens from wild-type (WT) and β 2 ARKO bone marrow transplantation (BMT) animals. B, Gravimetric analysis of spleen weight to body weight (SW/BW) of spleens from WT and β 2 ARKO BMT sham and myocardial infarction (MI) animals. n=6 for WT BMT sham; n=8 for β 2 ARKO BMT sham; n=4 for WT BMT 1 day; n=4 for β 2 ARKO BMT 1 day; n=10 for WT BMT 4 days; n=7 for β 2 ARKO BMT 4 days; n=7 for WT BMT 7 days; n=5 for β 2 ARKO BMT 7 days. Exact Wilcoxon rank-sum tests. *P<0.05. ‡P<0.001 versus WT BMT. c, Representative CD68, tryptase, and myeloperoxidase (MPO) staining from 4-day post-MI spleens of WT or β 2 ARKO BMT mice. d, Quantification of CD68, tryptase, and MPO staining from WT and β 2 ARKO BMT spleens 4 days after MI surgery. n=10 for WT BMT; n=8 for β 2 ARKO BMT. Exact Wilcoxon rank-sum tests. *P<0.05. ‡P<0.001 versus WT BMT. restoration of β 2 AR expression in β 2 ARKO macrophages ( Figure VE in the online-only Data Supplement) decreased VCAM-1 expression to that in WT macrophages ( Figure 5A ), whereas a GFP control lentivirus had no effect on VCAM-1 expression. Mechanistically, β 2 ARKO BM-derived macrophages transduced with β 2 AR GRK− had elevated expression of VCAM-1, whereas β 2 AR TYY had decreased VCAM-1 similar to WT levels ( Figure 5A ), indicating that GRK-dependent β 2 AR signaling is required for regulation of VCAM-1 expression in macrophages. In support of this observation, βARR2KO mice had splenomegaly similar to β 2 ARKO mice ( Figure 5B ) with retention of monocytes/macrophages, mast cells, and neutrophils ( Figure 5C and 5D ). Interestingly, βARR1KO mice had normal splenic size and leukocyte levels, indicating that β 2 AR regulates VCAM-1 expression selectively via βARR2 signaling.
splenectomized Wt and β 2 arKO BMt Mice have similar levels of leukocyte infiltration after acute Myocardial injury
To confirm whether splenic retention of β 2 ARKO leukocytes is primarily responsible for their decreased infiltration into the heart after MI, we examined leukocyte recruitment to the heart in splenectomized WT and β 2 ARKO BMT animals receiving sham or MI surgery d, Quantification of VCAM-1 immunoblot expression from the mice: n=12 for WT BMT, n=12 for β 2 ARKO BMT. Exact Wilcoxon rank-sum test. ‡P<0.001. e, Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to measure VCAM-1 expression in WT or β 2 ARKO BMT spleens and presented as relative quantitation (RQ)+RQ max . n=8 for WT BMT sham; n=6 for WT BMT myocardial infarction (MI); n=6 for β 2 ARKO BMT sham; n=8 for β 2 ARKO BMT MI. Exact Wilcoxon rank-sum tests. †P<0.01. ‡P<0.001 versus WT BMT. F, RT-qPCR was used to measure VCAM-1 expression in mouse (BM-derived macrophages [BMDMs]) or human (THP-1 derived) macrophages and presented as RQ+RQ max . n=7 for mouse vehicle; n=10 for mouse salbutamol; n=9 for human vehicle; n=10 for human salbutamol. Exact Wilcoxon rank-sum tests. †P<0.01. ‡P<0.001 versus vehicle. g, VCAM-1 expression in human macrophages treated with vehicle or ICI-118,551 was quantified by RT-qPCR and presented as RQ+RQ max . Exact Wilcoxon rank-sum test. †P<0.01 versus vehicle. h, RT-qPCR was used to measure VCAM-1 expression in human spleens from control or metoprolol-treated patients and presented as RQ+RQ max . n=5 for control; n=6 for metoprolol. Exact Wilcoxon rank-sum test. *P<0.05 versus control. A.U. indicates arbitrary units. Figure 6B ) and neutrophils ( Figure 6D ) into the border zone by ≈50%, with less impact on mast cells ( Figure 6C ). Conversely, splenectomy of β 2 ARKO BMT animals increased cardiac infiltration of monocytes/macrophages, neutrophils, and mast cells to levels not different from those observed in splenectomized WT BMT mice. Together, these results confirm that β 2 AR-deficient leukocytes accumulate in the spleen, where they remain after MI, but have the capacity to infiltrate the heart after injury in the absence of the spleen, similar to spleen-independent leukocyte infiltration levels attained in WT BMT mice.
Splenectomy in WT BMT animals decreased MI-induced infiltration of monocytes/macrophages (

restoration of β 2 ar expression reverses leukocyte dysfunction and restores survival rates after Mi
To determine whether restoration of β 2 AR expression in β 2 ARKO BM could revert the β 2 AR BMT phenotype to the WT BMT phenotype after MI, β 2 ARKO BM was transduced with the WT β 2 AR lentivirus construct or GFP control lentivirus before transplantation. Immunoblotting was used to confirm that the protein expression of GFP in control and Flag-tagged β 2 AR expression for lentivirus-transduced reconstituted BM ( Figure 7A ) and β 2 AR expression in β 2 ARKO BM after reconstitution were ≈95% of endogenous levels ( Figure 7B ). Similar to β 2 ARKO BMT mice, mice receiving β 2 ARKO BM transduced with GFP control lentivirus displayed 100% mortality after MI, with all mice dying between days 4 and 14 of cardiac rupture ( Figure 7C) ; however, restoration of β 2 AR expression in β 2 ARKO BM increased survival after MI to close to WT BMT levels ( Figure 7D ). Reconstitution with β 2 AR-infected β 2 ARKO BM also reduced both spleen size ( Figure 7E ) and VCAM-1 expression ( Figure 7F and 7G) compared with GFP-transduced β 2 ARKO BMT mice.
Accordingly, restoration of β 2 AR in β 2 ARKO BM also reduced levels of the leukocyte populations in the spleen (Figure 8A and 8B) to those not different from WT BMT mice (Table III in a, Reverse transcription-quantitative polymerase chain reaction was used to measure VCAM-1 expression in bone marrowderived macrophages (BMDMs) from wild-type (WT) or β 2 AR knockout (KO) mice and β 2 ARKO BMDMs transduced with green fluorescent protein (GFP), β 2 AR, β 2 AR TYY , or β 2 AR GRK− lentivirus and presented as relative quantitation (RQ)+RQ max . n=9 for WT; n=6 for β 2 ARKO; n=6 for β 2 ARKO+β 2 AR; n=6 for β 2 ARKO+GFP; n=6 for β 2 ARKO+β 2 AR TYY ; n=6 for β 2 ARKO+β 2 AR GRK− . Exact Wilcoxon rank-sum tests with multiple-comparison adjustment (5 comparisons). *P<0.05. †P<0.01 versus WT. B, Gravimetric analysis of spleen weight to body weight (SW/BW) of spleens from WT, β 2 ARKO, βARR1KO, and βARR2KO animals. n=7 for WT; n=6 for β 2 ARKO; n=6 for βARR1KO; n=6 for βARR2KO. Exact Wilcoxon rank-sum tests with multiple comparison adjustment (3 comparisons). †P<0.01 versus WT. c, Representative CD68, tryptase, and myeloperoxidase (MPO) staining of spleens from βARR1KO and βARR2KO mice. d, Quantification of CD68, tryptase, and MPO staining from βARR1KO and βARR2KO spleens. n=6 for βARR1KO; n=4 for βARR2KO. Exact Wilcoxon rank-sum tests. †P<0.01 versus βARR1KO.
versely, immunohistochemistry for leukocyte infiltration in sham ( Figure VII in the online-only Data Supplement) and injured myocardium of β 2 AR-rescued β 2 ARKO BMT mice revealed the reciprocal results. Thus, leukocyte infiltration was increased in the border ( Figure 8C ) and infarct ( Figure  VIII in the online-only Data Supplement) zones of the heart in β 2 ARKO BMT mice transduced with β 2 AR versus GFP lentivirus, including monocytes/macrophages, mast cells, and neutrophils ( Figure 8D ), which were restored to WT BMT levels ( Table III in discussiOn Inflammatory responses are critical for wound healing after MI. 1 All 3 βAR isoforms have been shown to mediate a number of effects in the immune system, including hematopoiesis, lymphocyte homing, and cytokine/chemokine production. However, little is known about how they regulate immune cell responses after acute cardiac injury. 10, 14 To investigate the immune cell-specific impact of βARs on cardiac survival and remodeling after MI, we generated chimeric mice lacking β 1 AR, β 2 AR, or β 3 AR expression on cells of hematopoietic origin. The most striking outcome was observed in β 2 ARKO BMT animals, which displayed 100% mortality resulting from cardiac rupture, in contrast to their WT counterparts, which had a ≈20% mortality rate. β 2 AR chimeric mice had decreased infiltration of leukocyte populations compared with their WT counterparts, demonstrating impaired innate immune responses. Recent findings have shown the importance of proinflammatory monocytes in initiating early immune cell-dependent reparative responses after MI. 2 Thus, it is likely that the inability of leukocyte populations to traffic to the heart acutely after MI in β 2 ARKO chimeric mice impairs early repair processes, contributing to scar instability, cardiac rupture, and death.
Of great importance, the β 2 ARKO BMT mice had decreased leukocyte infiltration into the heart after MI, with a reciprocal increase in spleen size and leukocyte retention, suggesting an impairment in immune cell egress from the spleen to the heart after acute cardiac injury. Thus, splenectomy of the β 2 ARKO BMT mice restored cardiac leukocyte infiltration responses to those of splenectomized WT BMT mice. Recently, the spleen has been shown to be an important monocyte reservoir, holding active monocytes for release on inflammatory injury, 6, 24 and has been demonstrated to be of particular importance after MI and during heart failure when there is increased antigen processing and adaptive immune system activation. 25 These processes are regulated through a variety of signals. 6 One molecular mechanism of leukocyte egress from the spleen through macrophage expression of VCAM-1 has recently been identified. 23 Our results demonstrate an increase in VCAM-1 in the macrophage-containing red pulp region of spleens from β 2 ARKO BMT animals, resulting in the retention of leukocyte populations in the spleens of these animals. VCAM-1 was also increased with a β 2 AR antagonist in human macrophages, with a reciprocal decrease in expression after β 2 AR stimulation. Interestingly, macrophage a, Representative immunoblot showing protein expression of green fluorescent protein (GFP) and Flag in reconstituted BM from β 2 ARKO, β 2 ARKO+GFP, and β 2 ARKO+β 2 AR BM transplantation (BMT) mice. β-tubulin, β-actin, and GAPDH are shown as loading controls. B, β 2 AR expression was measured by reverse transcription-quantitative polymerase chain reaction in reconstituted BM from wild-type (WT) and β 2 ARKO mice and reconstituted BM from mice that had GFP or β 2 AR transduced into β 2 ARKO BM by lentivirus before transplantation. Values are presented as relative quantitation (RQ)+RQ max expressed relative to WT BMT. n=10 for WT; n=10 for β 2 ARKO BMT; n=9 for β 2 ARKO+GFP BMT; n=11 for β 2 ARKO+β 2 AR BMT. Exact Wilcoxon rank-sum tests with multiple-comparison adjustment (3 comparisons). ‡P<0.001. c, β 2 ARKO+GFP and β 2 ARKO+β 2 AR BMT mice were subjected to sham or MI surgery and monitored daily for survival. All sham groups had 100% survival after surgery. n=6 for β 2 ARKO+GFP; n=7 for β 2 ARKO+β 2 AR BMT sham; n=27 for β 2 ARKO+GFP MI; n=26 for β 2 ARKO+β 2 AR BMT MI. Log-rank test. ‡P<0.001 versus β 2 ARKO+β 2 AR BMT. d, Percent survival of β 2 ARKO+GFP and β 2 ARKO+β 2 AR BMT mice 1 week after MI. Log-rank tests with multiple-comparison adjustment (3 comparisons). *P<0.05 versus WT BMT MI. e, Gravimetric analysis of spleen weight to body weight (SW/BW) of spleens from β 2 ARKO+GFP and β 2 ARKO+ β 2 AR BMT mice. n=7 for β 2 ARKO+GFP sham; n=6 for β 2 ARKO+ β 2 AR sham; n=8 for β 2 ARKO+GFP MI; and n=10 for β 2 ARKO+ β 2 AR MI. Exact Wilcoxon rank-sum tests. †P<0.01. ‡P<0.001 versus β 2 ARKO+GFP BMT. F, Representative vascular cell adhesion molecule-1 (VCAM-1) staining for β 2 ARKO+GFP and β 2 ARKO+β 2 AR BMT spleens 4 days after MI. g, Quantification of VCAM-1 intensity from immunohistochemistry of β 2 ARKO+GFP (n=6) and β 2 ARKO+β 2 AR BMT (n=7) spleens. Exact Wilcoxon rank-sum test. †P<0.01 versus β 2 ARKO+GFP BMT.
VCAM-1 expression appears to be regulated within this context in a β 2 AR/βARR2-dependent manner.
A common limitation of studies in mice is that the findings do not always translate to human pathophysiology. However, βAR activation has been implicated in reducing spleen size and release of certain immune cell populations in a number of different species, including murine and swine models and humans. [26] [27] [28] [29] [30] These changes were independent of alterations in blood flow, although the mechanism was never identified. Furthermore, β-blocker administration was shown to prevent the splenic release of immune populations, similar to our present study using β 2 ARKO chimeric animals, and this response was amplified when combined with an inflammatory stimulus. 31 Mechanistically, our study demonstrates increased levels of leukocyte populations in the spleens of β 2 ARKO BMT mice both before and after MI, effects that are clearly independent of vascular or splenic β 2 AR expression. Importantly, inhibition of leukocyte egress from the spleen and decreased infiltration of these populations into the heart can be reversed by restoring β 2 AR expression in the BM before transplantation using a lentiviral construct, confirming the specificity of the response and demonstrating the ability to modulate hematopoietic cell receptor expression using gene therapy approaches. In addition, our data in human macrophages are consistent with those in mouse macrophages, and we also observed increased VCAM-1 expression in the spleens of human donors who had taken the β-blocker metoprolol. Although metoprolol has preference for β 1 AR, it loses its selectivity at the higher doses often used clinically 32 that would also antagonize β 2 AR. This could account for the retention of immune cell populations observed in other studies and confirmed in our chimeric mouse model, providing further clinical relevance. Interestingly, increases in circulating immune cells with epinephrine or isoproterenol are greatly diminished in splenectomized patients, 33, 34 and multiple long-term studies examining the effects of splenectomy in humans have demonstrated an increased incidence in MI and heart failure with worsened prognosis after such events. 35, 36 Although many of the benefits of β-blockers are thought to be mediated through their actions on β 1 AR in cardiomyocytes, 37 immune cell-expressed βAR and β-blocker therapy have been suggested to play roles in the regulation of immune responses during heart failure. [38] [39] [40] [41] [42] Our findings suggest that the administration of β-blockers with selectivity to β 2 AR around the time †P<0.01. ‡P<0.001 versus β 2 ARKO+GFP BMT. c, Representative CD68, tryptase, and MPO staining of the border zone of hearts from β 2 ARKO+GFP and β 2 ARKO+β 2 AR BMT animals 4 days after MI surgery. d, Quantification of CD68, tryptase, and MPO staining from the border zone of 4-day post-MI hearts from β 2 ARKO+GFP (n=8) and β 2 ARKO+β 2 AR BMT (n=6) mice. Exact Wilcoxon rank-sum tests. ‡P<0.001 versus β 2 ARKO+GFP BMT. of MI could diminish leukocyte egress from the spleen and subsequent cardiac immune cell-dependent remodeling. The impact of such a process on overall cardiac remodeling would likely depend on the severity of β 2 AR inhibition; a short-term decrease in activity may simply dampen the inflammatory response but not ultimately prevent it, whereas long-term inhibition of leukocyte-expressed β 2 AR could negatively affect post-MI repair processes. Interestingly, it has recently been suggested that perioperative use of β-blockers may actually increase cardiovascular events, including MI, 43 and, according to the American Heart Association/American College of Cardiology, continues to have an uncertain mortality risk. 44 A link between β 2 AR inhibition in leukocytes and these clinical observations has not been demonstrated but warrants further investigation.
Unlike inhibition, short-term β 2 AR agonist administration during the inflammatory phase after MI in combination with long-term β 1 AR antagonist administration may be an improved therapeutic strategy to prevent detrimental remodeling and to preserve cardiac function after cardiac injury. Several studies investigating the use of β 2 AR agonists in the treatment of heart failure have found beneficial effects, which were attributed to the promotion of cardiomyocyte survival. However, the long-term benefits of βAR blockade in heart failure have contraindicated the use of β 2 AR agonists. [45] [46] [47] [48] [49] [50] In many of these studies, β 2 AR agonist administration began at later time points, thus missing the acute inflammatory phase. Regardless, in animal models, β 2 AR agonists have been shown to improve cardiac remodeling after MI or ischemia/reperfusion to a greater extent than that achieved by β 1 AR antagonists, 46, 49, 50 whereas cardiac function and survival were further improved with a combined β 1 AR blocker/β 2 AR agonist strategy. [46] [47] [48] Remarkably, a single dose of the β 2 AR agonist clenbuterol before ischemic insult was shown to decrease the resulting cardiac injury. 45 However, these studies did not assess the contribution of the early immune cell responses to their outcomes.
conclusions Using a chimeric mouse approach, we identified a critical role for hematopoietic cell-expressed β 2 AR in the regulation of acute cardiac inflammation and remodeling after MI. β 2 AR-deficient immune cells displayed impaired recruitment to the injured myocardium after MI, with reciprocal leukocyte retention within the spleen that was maintained after MI. Lentiviral-mediated re-expression of β 2 AR in β 2 ARKO BM before transplantation restored BM migration, splenic retention levels of leukocyte populations, and leukocyte infiltration into the heart after injury. Together, our results highlight an immunomodulatory role for β 2 AR that could be targeted to promote early leukocyte-dependent reparative processes after MI, with negligible or even beneficial effects on cardiomyocytes, while avoiding issues inherent to the promotion of prolonged inflammatory events. 
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